Business

Tesla shares rise after Musk's $5 billion stock sale

(Reuters) – Tesla shares rose in U.S. premarket trading on Thursday, even after overnight filings showed chief executive and top holder Elon Musk had sold about $5 billion of the stock over recent days.FILE PHOTO: A Tesla logo is seen at the Tesla Shanghai Gigafactory in Shanghai, China January 7, 2019. REUTERS/Aly SongThe electric-car maker’s […]

Business

Tesla's Musk sells some shares of EV maker, filings show

FILE PHOTO: SpaceX founder and Tesla CEO Elon Musk looks on as he visits the construction site of Tesla’s gigafactory in Gruenheide, near Berlin, Germany, May 17, 2021. REUTERS/Michele Tantussi/File Photo(Reuters) – Tesla Inc Chief Executive Officer Elon Musk disclosed in a filing on Wednesday that he had sold shares of the electric-car maker. Musk […]

Politics

Claire Trevett: A lot is at stake in Government’s ‘Olympics of Covid-19 Vaccinations’ but a medal could be tricky

OPINION The Government would have waited with bated breath to see how the mass vaccination event in Manukau kicked off yesterday. It was, as Minister Ayesha Verrall noted “the Olympics of Vaccinations”. The question was whether it would end up with a medal. The Government desperately needed it to. The Manukau event was intended to […]

Business

Carl Icahn sells over half his Herbalife stake for $600 million

(Reuters) – Activist investor Carl Icahn has sold more than half his stake in Herbalife Nutrition back to the company for $600 million at $48.05 a share and has given up the five seats on the firm’s board held by his representatives, Herbalife said in a statement.FILE PHOTO: An Herbalife logo is shown on a […]

Business

GSK sells $3.35 billion stake in Hindustan Unilever

HONG KONG/SINGAPORE (Reuters) – GlaxoSmithKline (GSK.L) said on Thursday it sold its stake in Unilever’s (ULVR.L) Indian business (HLL.NS) for $3.35 billion, which Refinitiv says is the largest block trade ever to have been carried out in India. The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly […]